Qatar · Startup

Denovo Sciences

ActiveUnverifiedRecord ID 7E3D3761

Summary

Business overview

Denovo Sciences builds AI-powered technologies for first-principles, structure-based drug discovery, designing small-molecule candidates where conventional methods fail.

Business activities

Not available

Registered trade names

Not available

Legal

Registration and legal

Registry number
Not available
Legal form
Startup
Incorporated
Not available
Registry authority
Not available
Licence status
Not available
Licence expiry
Not available
Share capital
Not available
Fiscal year end
Not available
Operational status
Active
Country
Qatar (QA)
Classification
Startup
Sub-classification
Not available

Footprint

Operations and locations

Headquarters
Not available
Employees
Not available
Operating languages
Not available
Licensed locations
Not available
Active branches
Not available
Cities covered
Not available

Branch register

No branch licences on record.

Office locations

  • Office

    Al Gharrafa Street, Al Rayyan, Education City, Doha, Qatar

  • Office

    138/2 Verin Antarain, Yerevan, Armenia

  • Office

    Qatar Science and Technology Park, 210000 Doha, Qatar

Public website

denovosciences.ai/

Estimates

Financials

Revenue, latest year
$00,000,000
Revenue, prior year
$00,000,000
Year on year growth
00%
Profitability
••••••••
Credit risk band
•• ••••
Funding rounds
•••• ••••

Premium data point

Revenue history, growth, profitability, credit banding and funding rounds are premium data points.

Unlock for $10 / month

Premium

Signals and buying intent

Buying intent score
00 / 100
Trend
••••••
Best time to reach out
•••••• ••••••

Topics being researched

•••••• •••••••• ••••• •••••• ••••••••

  • •••••••• •••••• •••• ••••••••

    ••••• ••••••••• •••••• ••••• •••••••• ••••••

  • •••••••• •••••• •••• ••••••••

    ••••• ••••••••• •••••• ••••• •••••••• ••••••

  • •••••••• •••••• •••• ••••••••

    ••••• ••••••••• •••••• ••••• •••••••• ••••••

Premium data point

Buying intent scoring, researched topics, outreach timing and the dated signal feed are released with premium access.

Unlock for $10 / month

Leadership

Decision makers (13)

  • Hamlet Khachatryan

    Computational Biologist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Hovakim Zakaryan

    Co-Founder, CEO

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Hovhannes Matevosyan

    Computational Chemist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Irina Tirosyan

    Senior Data Scientist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Julia Borzunova

    Computational Biologist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Marusya Ayvazyan

    Computational Biologist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Mher Matevosyan

    Co-Founder, CTO

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Narek Petrosyan

    Computational Chemist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • See More

    Grant Programs Manager

    manager

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Smbat Gevorgyan

    Computational Biologist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Vahe Petrosyan

    Data Scientist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Vardan Harutyunyan

    Co-founder, CAIO

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

  • Yeva Gabrielyan

    Senior Data Scientist

    Email: name.surname@company.qa

    Direct line: +974 0000 0000

Reporting structure

  • Hamlet Khachatryan

    Computational Biologist

  • Hovakim Zakaryan

    Co-Founder, CEO

  • Hovhannes Matevosyan

    Computational Chemist

  • Irina Tirosyan

    Senior Data Scientist

  • Julia Borzunova

    Computational Biologist

  • Marusya Ayvazyan

    Computational Biologist

  • Mher Matevosyan

    Co-Founder, CTO

  • Narek Petrosyan

    Computational Chemist

  • See More

    Grant Programs Manager

  • Smbat Gevorgyan

    Computational Biologist

  • Vahe Petrosyan

    Data Scientist

  • Vardan Harutyunyan

    Co-founder, CAIO

  • Yeva Gabrielyan

    Senior Data Scientist

Premium data point

Direct work emails and phone numbers for every decision maker are released with premium access.

Unlock for $10 / month

Network

Relationships and partnerships

Parent company
Independent entity
Subsidiaries
None on record
Group structure
Standalone

Partnerships

  • Weill Cornell Medicine-Qatar

    Collaboration to discover drug candidates for homocystinuria, announced October 2025

    Source
  • Sidra Medicine

    Collaboration to discover drug candidates for homocystinuria, announced October 2025

    Source
  • Mankind Pharma

    Strategic collaboration to launch AI-led drug discovery programme, announced July 2026

    Source
  • Flagship Pioneering

    Partner/investor in AI drug discovery platform

    Source
  • Oxford University

    Research partnership

    Source
  • CIRI

    Research partnership

    Source
  • CHUV (Centre Hospitalier Universitaire Vaudois)

    Research partnership

    Source
  • Agency

    Partner organization

    Source
  • Alchemist Doha

    Investor - $1M investment in 2025

    Source
  • Berkeley SkyDeck

    Investor/Accelerator

    Source
  • BAJ Accelerator

    Investor/Accelerator

    Source
  • Chuv

  • oxford

  • Weill Cornell

  • Footer

  • Email

  • Map Location

  • eye

Key clients

Not available

Competitors

Not available

Detected stack

Technology

  • Cloud and hosting

    •••••• ••••••

  • Business systems

    •••••• ••••••

  • Customer and marketing

    •••••• ••••••

Premium data point

Detected cloud, business, marketing, payment and security technologies are premium data points.

Unlock for $10 / month

Related records

Similar companies in Qatar

Common questions

Frequently asked questions about Denovo Sciences

Is Denovo Sciences an active registered company in Qatar?

Denovo Sciences is recorded as active in the Qatar company register. Varosyan LLC monitors the registry continuously, so a status change appears here within minutes of the source publishing it.

What does Denovo Sciences do?

Denovo Sciences builds AI-powered technologies for first-principles, structure-based drug discovery, designing small-molecule candidates where conventional methods fail. It is classified under Startup.

Who leads Denovo Sciences?

Hamlet Khachatryan is listed as Computational Biologist of Denovo Sciences. The record covers 13 decision makers with titles and reporting lines; direct work emails and phone numbers are premium data points.

Is Denovo Sciences company data free to access on Varosyan LLC?

Yes. The full registration record, classification, locations and leadership names are free to read, and a free account unlocks corporate contact details. Premium access at $10 per month adds direct contacts for decision makers, buying signals, financial estimates and unlimited downloads.